Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Pathologic Complete Response × Tacrolimus × 30 days × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 6 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Hematologic Neoplasms 4 Myelodysplastic Syndromes 3 Lymphoma 3 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3 Primary Myelofibrosis 2 Myeloproliferative Disorders 2 Myelodysplastic-Myeloproliferative Diseases 2 Lymphoproliferative Disorders 2 Lymphoma, Non-Hodgkin 2 Leukemia, Lymphoid 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Anemia, Refractory, with Excess of Blasts 2 beta-Thalassemia 1 Thalassemia 1 Shwachman-Diamond Syndrome 1 Sarcoma, Ewing 1 Rhabdomyosarcoma 1 Preleukemia 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precancerous Conditions 1 Osteosarcoma 1 Neuroblastoma 1 Neoplasms, Plasma Cell 1 Neoplasms by Histologic Type 1 Neoplasms 1 Multiple Myeloma 1 Lymphatic Diseases 1 Leukemia, Myeloid 1

Interventions

pembrolizumab 2 durvalumab 2 Standard of Care 2 Paclitaxel 2 Oxaliplatin 2 Irinotecan 2 Chemoradiotherapy 2 Carboplatin 2 Capecitabine 2 zanidatamab 1 veliparib 1 tucatinib 1 trilaciclib 1 trebananib 1 trastuzumab duocarmazine 1 tislelizumab 1 tegafur-gimeracil-oteracil 1 talazoparib 1 sarilumab 1 relugolix 1 regorafenib 1 pexidartinib 1 pertuzumab 1 patritumab 1 olaparib 1 niraparib 1 neratinib 1 ganitumab 1 enzalutamide 1 dostarlimab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡